Skip to main content
. 2020 May 29;74(2):91–97. doi: 10.1136/jclinpath-2020-206668

Figure 1.

Figure 1

Cohort of patients with lung cancer referred for epidermal growth factor receptor (EGFR) T790M ctDNA mutational status assessment. *Some patients received multiple subsequent tests, including serial blood and/or tissue biopsies from the same patient. TKI, tyrosine kinase inhibitor; UHN, University Health Network.